Literature DB >> 25312762

Eosinophils contribute to the resolution of lung-allergic responses following repeated allergen challenge.

Katsuyuki Takeda1, Yoshiki Shiraishi1, Shigeru Ashino1, Junyan Han1, Yi Jia1, Meiqin Wang1, Nancy A Lee2, James J Lee2, Erwin W Gelfand3.   

Abstract

BACKGROUND: Eosinophils accumulate at the site of allergic inflammation and are critical effector cells in allergic diseases. Recent studies have also suggested a role for eosinophils in the resolution of inflammation.
OBJECTIVE: To determine the role of eosinophils in the resolution phase of the response to repeated allergen challenge.
METHODS: Eosinophil-deficient (PHIL) and wild-type (WT) littermates were sensitized and challenged to ovalbumin (OVA) 7 or 11 times. Airway inflammation, airway hyperresponsiveness (AHR) to inhaled methacholine, bronchoalveolar lavage (BAL) cytokine levels, and lung histology were monitored. Intracellular cytokine levels in BAL leukocytes were analyzed by flow cytometry. Groups of OVA-sensitized PHIL mice received bone marrow from WT or IL-10(-/-) donors 30 days before the OVA challenge.
RESULTS: PHIL and WT mice developed similar levels of AHR and numbers of leukocytes and cytokine levels in BAL fluid after OVA sensitization and 7 airway challenges; no eosinophils were detected in the PHIL mice. Unlike WT mice, sensitized PHIL mice maintained AHR, lung inflammation, and increased levels of IL-4, IL-5, and IL-13 in BAL fluid after 11 challenges whereas IL-10 and TGF-β levels were decreased. Restoration of eosinophil numbers after injection of bone marrow from WT but not IL-10-deficient mice restored levels of IL-10 and TGF-β in BAL fluid as well as suppressed AHR and inflammation. Intracellular staining of BAL leukocytes revealed the capacity of eosinophils to produce IL-10.
CONCLUSIONS: After repeated allergen challenge, eosinophils appeared not essential for the development of AHR and lung inflammation but contributed to the resolution of AHR and inflammation by producing IL-10.
Copyright © 2014 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Eosinophils; IL-10; resolution of inflammation

Mesh:

Substances:

Year:  2014        PMID: 25312762      PMCID: PMC4587899          DOI: 10.1016/j.jaci.2014.08.014

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  68 in total

Review 1.  Eosinophils function as antigen-presenting cells.

Authors:  Huan-Zhong Shi
Journal:  J Leukoc Biol       Date:  2004-06-24       Impact factor: 4.962

Review 2.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red".

Authors:  James J Lee; Elizabeth A Jacobsen; Sergei I Ochkur; Michael P McGarry; Rachel M Condjella; Alfred D Doyle; Huijun Luo; Katie R Zellner; Cheryl A Protheroe; Lian Willetts; William E Lesuer; Dana C Colbert; Richard A Helmers; Paige Lacy; Redwan Moqbel; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2012-09       Impact factor: 10.793

3.  Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils.

Authors:  H Nakajima; G J Gleich; H Kita
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

Review 4.  Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models.

Authors:  Maggie J Leckie
Journal:  Am J Respir Med       Date:  2003

5.  In vitro assessment of chemokine receptor-ligand interactions mediating mouse eosinophil migration.

Authors:  Michael T Borchers; Tracy Ansay; Rob DeSalle; Bruce L Daugherty; Huahao Shen; Michael Metzger; Nancy A Lee; James J Lee
Journal:  J Leukoc Biol       Date:  2002-06       Impact factor: 4.962

6.  Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.

Authors:  Lisa A Spencer; Craig T Szela; Sandra A C Perez; Casey L Kirchhoffer; Josiane S Neves; Amy L Radke; Peter F Weller
Journal:  J Leukoc Biol       Date:  2008-10-07       Impact factor: 4.962

7.  Vaccine-induced CD8+ T cell-dependent suppression of airway hyperresponsiveness and inflammation.

Authors:  Katsuyuki Takeda; Steven W Dow; Nobuaki Miyahara; Taku Kodama; Toshiyuki Koya; Christian Taube; Anthony Joetham; Jung-Won Park; Azzeddine Dakhama; Ross M Kedl; Erwin W Gelfand
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

8.  Effects of overexpression of IL-10, IL-12, TGF-beta and IL-4 on allergen induced change in bronchial responsiveness.

Authors:  Chi-Ling Fu; Yi-Ling Ye; Yueh-Lun Lee; Bor-Luen Chiang
Journal:  Respir Res       Date:  2006-05-08

9.  Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.

Authors:  WanJun Chen; Wenwen Jin; Neil Hardegen; Ke-Jian Lei; Li Li; Nancy Marinos; George McGrady; Sharon M Wahl
Journal:  J Exp Med       Date:  2003-12-15       Impact factor: 14.307

10.  CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis.

Authors:  Charles F Anderson; Mohammed Oukka; Vijay J Kuchroo; David Sacks
Journal:  J Exp Med       Date:  2007-02-05       Impact factor: 14.307

View more
  18 in total

Review 1.  Update on reslizumab for eosinophilic asthma.

Authors:  Juan Carlos Cardet; Elliot Israel
Journal:  Expert Opin Biol Ther       Date:  2015       Impact factor: 4.388

Review 2.  Shaping eosinophil identity in the tissue contexts of development, homeostasis, and disease.

Authors:  Hiam Abdala-Valencia; Mackenzie E Coden; Sergio E Chiarella; Elizabeth A Jacobsen; Bruce S Bochner; James J Lee; Sergejs Berdnikovs
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

3.  Differential activation of airway eosinophils induces IL-13-mediated allergic Th2 pulmonary responses in mice.

Authors:  E A Jacobsen; A D Doyle; D C Colbert; K R Zellner; C A Protheroe; W E LeSuer; N A Lee; J J Lee
Journal:  Allergy       Date:  2015-06-14       Impact factor: 13.146

4.  Eosinophils and eosinophil-associated diseases: An update.

Authors:  Jeremy A O'Sullivan; Bruce S Bochner
Journal:  J Allergy Clin Immunol       Date:  2017-10-16       Impact factor: 10.793

5.  Hepatic recruitment of eosinophils and their protective function during acute liver injury.

Authors:  Long Xu; Yang Yang; Yankai Wen; Jong-Min Jeong; Christoph Emontzpohl; Constance L Atkins; Zhaoli Sun; Kyle L Poulsen; David R Hall; J Steve Bynon; Bin Gao; William M Lee; Jody Rule; Elizabeth A Jacobsen; Hua Wang; Cynthia Ju
Journal:  J Hepatol       Date:  2022-03-05       Impact factor: 30.083

6.  IL-4-secreting eosinophils promote endometrial stromal cell proliferation and prevent Chlamydia-induced upper genital tract damage.

Authors:  Rodolfo D Vicetti Miguel; Nirk E Quispe Calla; Darlene Dixon; Robert A Foster; Andrea Gambotto; Stephen D Pavelko; Luanne Hall-Stoodley; Thomas L Cherpes
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-01       Impact factor: 11.205

7.  Chronic oral exposure to glycated whey proteins increases survival of aged male NOD mice with autoimmune prostatitis by regulating the gut microbiome and anti-inflammatory responses.

Authors:  Yingjia Chen; Kevin M Guo; Tamas Nagy; Tai L Guo
Journal:  Food Funct       Date:  2020-01-29       Impact factor: 5.396

8.  Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies.

Authors:  Elizabeth A Jacobsen; David J Jackson; Enrico Heffler; Sameer K Mathur; Albert J Bredenoord; Ian D Pavord; Praveen Akuthota; Florence Roufosse; Marc E Rothenberg
Journal:  Annu Rev Immunol       Date:  2021-03-01       Impact factor: 28.527

Review 9.  Innate immunity is a key factor for the resolution of inflammation in asthma.

Authors:  Cindy Barnig; Bruce D Levy
Journal:  Eur Respir Rev       Date:  2015-03

10.  Methanosphaera stadtmanae induces a type IV hypersensitivity response in a mouse model of airway inflammation.

Authors:  Emilie Bernatchez; Matthew J Gold; Anick Langlois; Pascale Blais-Lecours; Magali Boucher; Caroline Duchaine; David Marsolais; Kelly M McNagny; Marie-Renée Blanchet
Journal:  Physiol Rep       Date:  2017-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.